Jim Simons Axcella Health Inc. Transaction History

Renaissance Technologies LLC

  • $56.7 Billion
  • Q2 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$0.22 - $0.46 $2,046 - $4,278
-9,300 Reduced 41.7%
13,000 $3,000
Q1 2023

May 12, 2023
SELL
$0.31 - $0.77 $6,789 - $16,863
-21,900 Reduced 49.55%
22,300 $11,000
Q4 2022

Feb 13, 2023
SELL
$0.16 - $1.1 $1,536 - $10,560
-9,600 Reduced 17.84%
44,200 $14,000
Q3 2022

Nov 14, 2022
SELL
$1.62 - $2.73 $3,078 - $5,187
-1,900 Reduced 3.41%
53,800 $92,000
Q2 2022

Aug 12, 2022
BUY
$1.41 - $2.77 $9,588 - $18,836
6,800 Added 13.91%
55,700 $113,000
Q1 2022

May 13, 2022
BUY
$1.58 - $2.82 $3,634 - $6,486
2,300 Added 4.94%
48,900 $126,000
Q4 2021

Feb 11, 2022
SELL
$2.06 - $3.61 $7,551 - $13,234
-3,666 Reduced 7.29%
46,600 $97,000
Q3 2021

Nov 12, 2021
SELL
$2.98 - $4.31 $321,649 - $465,204
-107,936 Reduced 68.23%
50,266 $150,000
Q2 2021

Aug 13, 2021
BUY
$3.08 - $5.13 $274,474 - $457,159
89,115 Added 128.99%
158,202 $634,000
Q1 2021

May 13, 2021
BUY
$4.55 - $6.72 $46,805 - $69,128
10,287 Added 17.49%
69,087 $329,000
Q4 2020

Feb 10, 2021
BUY
$4.24 - $5.97 $10,176 - $14,328
2,400 Added 4.26%
58,800 $305,000
Q3 2020

Nov 13, 2020
SELL
$4.12 - $5.91 $504,288 - $723,384
-122,400 Reduced 68.46%
56,400 $261,000
Q2 2020

Aug 13, 2020
BUY
$2.94 - $7.7 $525,672 - $1.38 Million
178,800 New
178,800 $989,000

Others Institutions Holding AXLA

# of Institutions
2
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About Axcella Health Inc.

AXLA Quotes by TradingView
  • Ticker AXLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,500,896
  • Description
  • Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...
More about AXLA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email